1. |
李子颖, 李士雨, 齐向娟. 青蒿素提取技术研究进展 [J]. 中药研究与信息, 2002; 4(2): 17-21.
|
2. |
Lee S. Artemisinin, promising lead natural product for various drug developments [J]. Mini Rev Med Chem, 2007; 7(4): 411-422.
|
3. |
Dhingra V, Vishweshwar Rao K, Lakshmi Narasu M. Current status of artemisinin and its derivatives as antimalarial drugs [J]. Life Sci, 2000; 66(4): 279-300.
|
4. |
郑全芳, 杨志刚, 孙红祥. 青蒿素及其衍生物药理作用研究进展 [J]. 中国兽药杂志, 2006; 40(1): 40-44.
|
5. |
Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells [J]. Curr Drug Targets, 2006; 7(4): 407-421.
|
6. |
茹炜炜, 梁幼生. 青蒿素类药物抗寄生虫作用研究进展 [J]. 中国血吸虫病防治杂志, 2006; 18(1): 78-80.
|
7. |
Lai H, Singh NP. Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat [J]. Cancer Lett, 2006; 231(1): 43-48.
|
8. |
Anfosso L, Efferth T, Albini A, et al. Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins [J]. Pharmacogenomics J, 2006; 6(4): 269-278.
|
9. |
Fujita T, Felix K, Pinkaew D, et al. Human fortilin is a molecular target of dihydroartemisinin [J]. FEBS Lett, 2008; 582(7): 1055-1060.
|
10. |
Berger TG, Dieckmann D, Efferth T, et al. Artesunate in the treatment of metastatic uveal melanoma-irst experiences [J]. Oncol Rep, 2005; 14(6): 1599-1603.
|
11. |
Yamachika E, Habte T, Oda D. Artemisinin: an alternative treatment for oral squamous cell carcinoma [J]. Anticancer Res, 2004; 24(4): 2153-2160.
|
12. |
Huang XJ, Ma ZQ, Zhang WP, et al. Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells [J]. J Pharm Pharmacol, 2007; 59(6): 849-856.
|
13. |
Mu D, Chen W, Yu B, et al. Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells [J]. Methods Find Exp Clin Pharmacol, 2007; 29(1): 33-38.
|
14. |
Mu D, Zhang W, Chu D, et al. The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells [J]. Cancer Chemother Pharmacol, 2008; 61(4): 639-645.
|
15. |
Li LN, Zhang HD, Yuan SJ, et al. Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway [J]. Int J Cancer, 2007; 121(6): 1360-1365.
|
16. |
Lee J, Zhou HJ, Wu XH. Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells [J]. Cancer Chemother Pharmacol, 2006; 57(2): 213-220.
|
17. |
Hou J, Wang D, Zhang R, et al. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action [J]. Clin Cancer Res, 2008; 14(17): 5519-5530.
|
18. |
Zhou HJ, Wang Z, Li A. Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression [J]. Anticancer Drugs, 2008; 19(3): 247-255.
|
19. |
Nakase I, Lai H, Singh NP, et al. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation [J]. Int J Pharm, 2008; 354(1-2): 28-33.
|
20. |
Li LN, Zhang HD, Yuan SJ, et al. Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin [J]. Eur J Pharmacol, 2008; 588(1): 1-8.
|
21. |
董海鹰, 王知非, 宋维华, 等. 青蒿素诱导K562细胞凋亡研究 [J]. 中国肿瘤, 2003; 12(8): 473-475.
|
22. |
王勤, 吴理茂, 赵一, 等. 青蒿琥酯抗肿瘤作用的机制研究 [J]. 药学学报, 2002; 37(6): 477-478.
|
23. |
周晋, 孟然, 李丽敏, 等. 青蒿素对人白血病细胞株和原代细胞的影响 [J]. 中华内科杂志, 2003; 42(10): 713-714.
|
24. |
Chen HH, Zhou HJ, Wu GD, et al. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1 [J]. Pharmacology, 2004; 71(1): 1-9.
|
25. |
Efferth T. Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin-from bench to bedside [J]. Planta Med, 2007; 73(4): 299-309.
|
26. |
Yang ZS, Zhou WL, Sui Y, et al. Synthesis and immunosuppressive activity of new artemisinin derivatives. 1. [12(beta or alpha)-Dihydroartemisininoxy] phen(ox)yl aliphatic acids and esters [J]. J Med Chem, 2005; 48(14): 4608-4617.
|
27. |
Yang ZS, Wang JX, Zhou Y, et al. Synthesis and immunosuppressive activity of new artemisinin derivatives. Part 2: 2-[12(beta or alpha)-dihydroartemisinoxymethyl(or 1′-ethyl)] phenoxyl propionic acids and esters [J]. Bioorg Med Chem, 2006; 14(23): 8043-8049.
|
28. |
Zhou WL, Wu JM, Wu QL, et al. A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo [J]. Acta Pharmacol Sin, 2005; 26(11): 1352-1358.
|
29. |
徐丽敏, 陈学荣, 屠呦呦. 双氢青蒿素对狼疮性BXSB小鼠的作用 [J]. 中国中西医结合皮肤性病学杂志, 2002; 1(1):19-20.
|
30. |
蒋江红. 青蒿琥酯的药理研究纂要 [J]. 中医药学刊, 2003; 21(9): 1502-1503.
|
31. |
徐继红, 章元沛. 二氢青蒿素与青蒿琥酯的抗孕作用 [J]. 药学学报, 1996; 31(9): 657-661.
|
32. |
娄小娥, 周慧君. 青蒿琥酯对大鼠孕酮、雌二醇和蜕膜组织的影响 [J]. 药学学报, 2001; 36(4): 254-257.
|
33. |
曹治东, 石崇荣, 黄崇本. 青蒿素对体外瘢痕成纤维细胞的生物学影响 [J]. 重庆医学, 2003; 32(5): 521-523.
|
34. |
郑红艳. 青蒿素母液体外抗真菌试验 [J]. 四川畜牧兽医, 2001; 28(5): 33-34.
|
35. |
卢岚. 冬虫夏草和青蒿素抑制狼疮性肾炎复发的研究 [J]. 中国中西医结合杂志, 2002; 22(3): 169-171.
|
36. |
刘云海, 杜光. 青蒿素等中药化学成分抗内毒素研究现状 [J]. 医药导报, 2001; 20(8): 525-526.
|